Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.

Study finds mosaicism in Down syndrome reduces Alzheimer's risk, providing new insights into genetic influences on cognitive ...

The treatment of dementia disorders such as Alzheimer's is still one of the greatest challenges facing modern medicine. In ...

A finger-prick blood test can accurately identify p-tau217 — a key biomarker of Alzheimer's disease (AD) — without the need ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

On 23 October 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s anti-amyloid beta (Aβ) monoclonal antibody (mAb) Kisunla for the treatment of patients with mild ...

Nov. 6, 2024 — Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

As the disease progresses to moderate dementia, damage in areas of the brain that control language, reasoning, conscious thought, and sensory processing lead to more severe symptoms.

Results indicated PMN310 was generally well-tolerated and monthly dosing can provide CSF levels adequate for target ...

In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Inmune Bio (INMB – Research Report), with a price ...

New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s disease related amyloid pathology with very good accuracy. In the largest ...